Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement

June 27, 2024

The deal offers member pharmacies two pricing options, which will take effect Aug. 1.

The Association Between 340B Program Involvement and Availability of Hospital Services

June 27, 2024

A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

June 27, 2024

The latest news for pharma industry insiders.

Pharma pulse 6/25/24: Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

June 25, 2024

The latest news for pharma industry insiders.

Investigating the Cost-Effectiveness of Durvalumab

June 24, 2024

A study examines the economical validity of using this therapy as a treatment for unresectable stage III non–small cell lung cancer.